Drug Shortage Report for TEVA-PREDNISOLONE
Report ID | 172030 |
Drug Identification Number | 00700401 |
Brand name | TEVA-PREDNISOLONE |
Common or Proper name | TEVA-PREDNISOLONE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PREDNISOLONE ACETATE |
Strength(s) | 1% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-17 |
Estimated end date | 2023-05-30 |
Actual end date | 2023-06-08 |
Shortage status | Resolved |
Updated date | 2023-06-09 |
Company comments | 5ml is OOS, 10ml is under allocations |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v28 | 2023-06-09 | English | Compare |
v27 | 2023-06-08 | French | Compare |
v26 | 2023-06-08 | English | Compare |
v25 | 2023-04-27 | French | Compare |
v24 | 2023-04-27 | English | Compare |
v23 | 2023-04-14 | French | Compare |
v22 | 2023-04-14 | English | Compare |
v21 | 2023-02-16 | French | Compare |
v20 | 2023-02-16 | English | Compare |
v19 | 2023-02-16 | English | Compare |
v18 | 2023-02-02 | French | Compare |
v17 | 2023-02-02 | English | Compare |
v16 | 2023-01-12 | French | Compare |
v15 | 2023-01-12 | English | Compare |
v14 | 2022-12-15 | French | Compare |
v13 | 2022-12-15 | English | Compare |
v12 | 2022-12-08 | French | Compare |
v11 | 2022-12-08 | English | Compare |
v10 | 2022-12-01 | French | Compare |
v9 | 2022-12-01 | English | Compare |